logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: diagnostic-laboratories
Load new posts () and activity
Like Reblog Comment
text 2020-03-31 11:26
Solvent Evaporation Market worth $694 million by 2024– Exclusive Report by MarketsandMarkets™

 According to the new market research report "Solvent Evaporation Market by Evaporator Type (Rotary Evaporator, Nitrogen Blow Down Evaporator, Centrifugal Evaporator), End-User (Pharmaceutical & Biopharmaceutical, Diagnostic Laboratories, Research & Academic Institute), Region - Global Forecast to 2024", published by MarketsandMarkets™, This study involved the extensive use of both primary and secondary sources.

Access Free Sample Research Copy : https://www.marketsandmarkets.com/requestsampleNew.asp?id=68290365


 

Growth in this market is driven majorly by the growth of the biologics sector, increasing research & development expenditure, rising purity demands in end-use markets, and the growing development of large molecule biopharmaceuticals.

The research & academic institutes segment is expected to grow at the highest CAGR during the forecast period. The growth in this segment can be attributed to factors such as the increasing drug development studies and the rising demand for continuous innovation and enhancement of existing products.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=68290365

The rotary evaporators segment is expected to account for the largest solvent evaporators market share in 2018 :

Rotary evaporators are expected to be the most significant revenue contributor to the global market in 2018. The large share of this segment can be attributed to the increasing demand for efficient & pure samples, growing investments in research & development by research institutes, rising demand for industrial-scale automation in terms of digitization, and the growing need for advanced analytical tools during drug diagnosis & research studies.

What Drives the Market?

- Increasing R&D Expenditure
- Increasing Demand for Pure Samples in End-Use Markets
- Growing Development of Large-Molecule Biopharmaceuticals

Geographical Growth Analysis:

The North American market accounted for the largest share of the solvent evaporators industry in 2018. This is attributed to the increase in life sciences R&D, rising focus on improving the safety & quality of healthcare, growing efforts to increase the output of the healthcare industry, growth in the biosimilars & generics market, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment.

Get Expert Analysis and Insights of Global Market | Enquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=68290365

Source: www.marketsandmarkets.com/Market-Reports/solvent-evaporation-market-68290365.html#
Like Reblog Comment
text 2020-02-19 04:30
Non Invasive Prenatal Testing (NIPT) :Latest Trends & Industry Vision by 2024

According to the new market research report “Non-Invasive Prenatal Testing Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690

The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT. However, a dearth of skilled professionals is restraining the growth of this market.

Key Players in the Global NIPT Market

The NIPT market is diversified and highly competitive, with a large number of players competing for market space. The prominent players in the market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), GE Healthcare (US), BGI (China), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer Inc. (US), Laboratory Corporation of America Holdings (US), Natera, Inc. (US), and Yourgene Health (UK)

Inquire or share your questions if any before the purchasing this report
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=145607690

Growth prospects in Non Invasive Prenatal Testing (NIPT) Market :

The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT. However, a dearth of skilled professionals is restraining the growth of this market.

By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests. The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period.

Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type). In 2018, trisomy was the largest application segment of the NIPT market.

Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals. In 2019, diagnostic laboratories formed the largest and fastest-growing end users of NIPT products.

Source: www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html
Like Reblog Comment
text 2019-12-06 08:28
Creatinine Measurement Market – Top 3 Players and there Market Growth

Increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives. 

Market Size 
The global Creatinine Measurement market size is projected to reach USD 700.8 million by 2027 from USD 377.2 million in 2018, at a CAGR of 8.4%. 

F. Hoffmann-la Roche Ltd (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Thermo Fisher Scientific (US), Siemens Healthineers (Germany), Randox Laboratories (UK), Pointe Scientific (US), Sentinel Ch. Spa. (Italy), Diasys Diagnostic Systems GmbH (Germany), Dialab GmbH (Vienna), Diazyme Laboratories (US), Wako Pure Chemical Industries, Ltd. (Japan), Ortho Clinical Diagnostics (US), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China) are some key players in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, acquisitions, and expansions. 

For More Details, Download a PDF Brochure:- 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206847385 


“F. Hoffmann-La Roche was the leading player in the creatinine measurement market in 2017” 
The dominant share of this company is attributed to its exhaustive product portfolio and strong global reach, especially in the emerging economies. For maintaining its market position, the company mainly focuses on investments toward R&D activities to fuel innovation. The company invested USD 10.18 billion (19.5% of total sales) on R&D activities in 2017. With its strong R&D capabilities and state-of-the-art asset quality, the company is also expected to grow during the forecast period. 

“Danaher is one of the major players in the creatinine measurement market” 

The company has a strong brand name in high-growth geographies and a growing presence in the emerging markets. The company has a strong focus on research and development and spent USD 1,128.8 million on R&D in 2017. The company has a vast geographic presence in over 60 countries. Beckman Coulter (Danaher’s parent company) provides customer sales support in remote locations through its PROService Remote Diagnostics. 

We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Request Sample Pages:- 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=206847385

More posts
Your Dashboard view:
Need help?